In peritoneal dialysis, how does icodextrin (7.5% high‑molecular‑weight glucose polymer) achieve better ultrafiltration than conventional dextrose solutions (1.5‑2.5%)?

Icodextrin Achieves Better Ultrafiltration Through Less Absorption (Answer A)

Icodextrin works better than conventional dextrose solutions for ultrafiltration primarily because its high molecular weight (16,200 Da) results in significantly slower absorption from the peritoneal cavity, maintaining sustained colloid osmotic pressure throughout long dwells. 1

Mechanism of Action

Why Less Absorption is Key

Icodextrin's superiority stems from its fundamental pharmacokinetic difference from glucose:

• Molecular weight matters: As a glucose polymer with molecular weight around 16,200 Da, icodextrin is absorbed much more slowly across the peritoneal membrane compared to the small glucose molecules (180 Da) in conventional solutions 1

• Sustained osmotic gradient: This slow absorption means the osmotic driving force persists throughout the entire dwell period, particularly critical during long 8-16 hour dwells where glucose solutions fail 2

• Linear ultrafiltration profile: Studies demonstrate that transcapillary ultrafiltration increases linearly over time with icodextrin, whereas glucose-based solutions show a hyperbolic decline as glucose is rapidly absorbed 1

Colloid vs Crystalloid Osmosis

Icodextrin generates ultrafiltration through colloid osmosis rather than crystalloid osmosis 3:

• The 7.5% icodextrin solution is actually iso-osmotic to plasma (284 mOsmol/L) 4, not hypertonic like glucose solutions
• This directly contradicts option B (increased osmolality) - icodextrin does NOT work through higher osmolality
• Instead, it exerts oncotic pressure across intercellular pores with radii of approximately 40 Å 1

Clinical Evidence from Guidelines

The American Journal of Kidney Diseases guidelines explicitly state that icodextrin is the preferred strategy for long-duration dwells because it avoids the problem of "net fluid resorption" that occurs with glucose solutions 2:

• Long dwells with glucose are "associated with ineffective fluid removal or even net fluid resorption" 2
• Icodextrin was shown in RCTs to "both increase peritoneal ultrafiltration and decrease ECF volume" 2
• With icodextrin, "there is no need to drain a day dwell early to optimize ultrafiltration" 2

Why Other Options Are Incorrect

Option B (Increased osmolality): Definitively wrong. Icodextrin is iso-osmotic at 284 mOsmol/L 4, whereas 3.86% glucose solutions are hypertonic. The mechanism is colloid osmosis, not crystalloid osmosis.

Option C (Diuretic effect): Incorrect. Icodextrin has no diuretic properties. The guidelines discuss loop diuretics as a separate intervention for patients with residual kidney function 2, but icodextrin works purely through peritoneal ultrafiltration.

Option D (Less risk of infection): Not the mechanism of better ultrafiltration. While infection rates are similar between icodextrin and glucose 5, this doesn't explain the ultrafiltration advantage.

Quantitative Superiority

The meta-analysis of 19 RCTs involving 1,693 participants demonstrated icodextrin improved ultrafiltration by 208.92 mL/24h (95% CI: 99.69-318.14) compared to glucose solutions 6. This translated to:

• Fewer episodes of fluid overload (RR 0.43,95% CI 0.24-0.78) 6
• Probable mortality benefit (Peto OR 0.49,95% CI 0.24-1.00) 6
• Sustained ultrafiltration even during peritonitis episodes 3

Clinical Pearls

Common pitfall: Don't assume icodextrin works like concentrated glucose. The 7.5% concentration refers to polymer content, not osmolality. The solution is iso-osmotic but maintains its osmotic effect through slow absorption 1.

Special advantage in high transporters: Icodextrin is particularly beneficial in patients with high peritoneal membrane permeability, where glucose is absorbed so rapidly that ultrafiltration fails 7, 6. The positive correlation between peritoneal surface area and icodextrin ultrafiltration (r=0.66, P=0.05) means these patients actually benefit MORE from icodextrin 1.

Carbohydrate absorption: Icodextrin absorption averages only 40-60% of the glucose absorbed from 2.5-4.25% dextrose exchanges during long dwells 6, providing metabolic advantages beyond just ultrafiltration.